Hsu C.-S.JIA-HORNG KAO2021-09-042021-09-0420120929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867899419&doi=10.1016%2fj.jfma.2012.07.002&partnerID=40&md5=b561d30ce4f8f4c4460aac559a09317dhttps://scholars.lib.ntu.edu.tw/handle/123456789/582028Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in Western countries, and has become increasingly recognized as a public health problem in Taiwan. Patients with non-alcoholic steatohepatitis, a more severe form of NAFLD, may progress to cirrhosis and its related complications, including hepatocellular carcinoma. Since NAFLD is highly linked to metabolic syndrome, such patients may have increased risks of complications related to both liver disease and metabolic syndrome. Therefore, if we fail to cope with this growing health problem, NAFLD may gradually replace viral hepatitis as the major etiology of liver disease in Taiwan. ? 2012.ALT; APASL; CHB/C; Fatty liver; HB/CV; HCC; Hepatitis B virus; Hepatitis C virus; HOMA-IR; Metabolic syndrome; MetS; NAFLD; NASH; T2DM; Taiwan[SDGs]SDG3alanine aminotransferase; interferon; ribavirin; rosiglitazone; alanine aminotransferase blood level; anthropometry; computer assisted tomography; diet therapy; disease association; disease course; disease severity; echography; hepatitis C; human; kinesiotherapy; laparoscopy; lifestyle modification; liver biopsy; liver cell carcinoma; liver disease; liver failure; metabolic syndrome X; non insulin dependent diabetes mellitus; nonalcoholic fatty liver; obesity; pathogenesis; pathophysiology; patient assessment; prevalence; review; risk; Southeast Asia; Taiwan; virus hepatitis; Fatty Liver; Hepatitis C, Chronic; Humans; Prevalence; Risk Factors; Taiwanreview10.1016/j.jfma.2012.07.002230896872-s2.0-84867899419